Lymphocyte labeling with technetium-99m-HMPAO: a radiotoxicity study using the micronucleus assay.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Journal of Nuclear Medicine

• Publication date

  1992-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 1597733
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Whole body distribution of 99mTc labelled autologous human granulocytes and radiation dose to cells and organs

  2004cited by this paper
• Lymphocyte labelling with indium: Cytotoxicity studies

  2004cited by this paper
• Migration of 99mTc-labelled syngeneic lymphocytes in the rat. Biological and theoretical models predict radiation damage and poor scintigraphic detectability.

  1990cited by this paper
• In vivo traffic of indium-111-oxine labeled human lymphocytes collected by automated apheresis.

  1990cited by this paper
• Limitations of conventional internal dosimetry at the cellular level.

  1989cited by this paper
• In vitro and in vivo evaluation of granulocyte labeling with [99mTc]d,1-HM-PAO.

  1989cited by this paper
• Technetium-99m HM-PAO-labeled leukocytes in detection of inflammatory lesions: comparison with gallium-67 citrate.

  1989cited by this paper
• Comparative human cellular radiosensitivity: II. The survival following gamma-irradiation of unstimulated (G0) T-lymphocytes, T-lymphocyte lines, lymphoblastoid cell lines and fibroblasts from normal donors, from ataxia-telangiectasia patients and from ataxia-telangiectasia heterozygotes.

  1988cited by this paper
• Comparison of 99Tcm‐HMPAO and 111In‐oxine labelled granulocytes in man: first clinical results

  1988cited by this paper
• Inflammation: imaging with Tc-99m HMPAO-labeled leukocytes.

  1988cited by this paper
• The development of a clinical protocol for the radiolabelling of mixed leucocytes with 99Tcm‐hexamethylpropyleneamine oxime

  1988cited by this paper
• The present state and perspectives of micronucleus assay in radiation protection. A review.

  1987cited by this paper
• Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation.

  1986cited by this paper
• Technetium-99m-labeled lymphocytes: a radiotoxicity study.

  1986cited by this paper
• Measurement of micronuclei in lymphocytes.

  1985cited by this paper
• A new method for rapid technetium-99m labelling of leucocytes: functional cell studies in vitro.

  1985cited by this paper
• Re: Labeling with indium-111 has detrimental effects on human lymphocytes.

  1984cited by this paper
• The significance of chromosomal aberrations in indium-111-labeled lymphocytes.

  1984cited by this paper
• Re: Labeling with Indium-111 Has Detrimental Effects on Human Lymphocytes—Reply

  1984cited by this paper
• Thallium-201: an experimental and a theoretical radiobiological approach to dosimetry.

  1983cited by this paper
• Labeling with indium-111 has detrimental effects on human lymphocytes: concise communication.

  1983cited by this paper
• Biological effects and irradiation dose induced in human lymphocytes in vitro by an intracellular radionuclide:99mTc.

  1983cited by this paper
• Recirculation of lymphocytes and the use of indium-111.

  1979cited by this paper
• Cell damage resulting from the labeling of rat lymphocytes and HeLa S3 cells with In-111 oxine.

  1979cited by this paper
• Dose received by lymphocytes in the course of labeling techniques using Tc-99m.

  1978cited by this paper
• Absorption of 20-eV to 50,000-eV electron beams in air and plastic.

  1969cited by this paper

• Predicting radiation‐induced immune suppression in lung cancer patients treated with stereotactic body radiation therapy

  2024cites this paper
• Direct Cell Radiolabeling for in Vivo Cell Tracking with PET and SPECT Imaging

  2022cites this paper
• HMGB1 expression in leukocytes as a biomarker of cellular damage induced by [99mTc]Tc-HMPAO-labelling procedure: A quality control study.

  2021cites this paper
• Clinical Applications of Biological Dosimetry in Patients Exposed to Low Dose Radiation Due to Radiological, Imaging or Nuclear Medicine Procedures.

  2021cites this paper
• Granulocyte radiolabelling using Leukokit® with introduction of a density gradient medium as ancillary material.

  2020cites this paper
• Chromosome aberrations during in-vitro labeling of red blood cells with 99mTc: a study with cytokinesis block micronucleus assay in human peripheral blood lymphocytes

  2020cites this paper
• Novel approach for quality assessment and improving diagnostic accuracy in cell-based infection imaging using 99mTc-HMPAO labeled leukocytes

  2018cites this paper
• Utilitat diagnòstica dels leucòcits marcats amb Tecneci-99m en la pràctica diària hospitalària

  2016cites this paper
• Quantification of the chromosomal radiation damage induced by labelling of leukocytes with [18F]FDG.

  2015influential citation
• Imaging Neuroinflammation – from Bench to Bedside

  2014cites this paper
• Guidelines for the labelling of leucocytes with 99mTc-HMPAO

  2010cites this paper
• Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine.

  2010cites this paper
• 99mTc-HMPAO labelling inhibits cell motility and cell proliferation and induces apoptosis of NC-NC cells.

  2007cites this paper
• Cellular Labeling with 99m Tc Chelates: Relevance of In Vitro and In Vivo Viability Testing

  2007cites this paper
• Detection of 111In-oxine-labeled bone marrow stromal cells after intravenous or intralesional administration in chronic paraplegic rats.

  2005cites this paper
• Radiolabelled leukocytes for imaging inflammation: how radiochemistry affects clinical use.

  2005cites this paper
• Distribution of 99mTc-labeled lymphocytes in control and inflamed rats.

  2004cites this paper
• A Novel Method of Brachytherapy Using Local Delivery of 99mTc–HMPAO for Coronary Stent Restenosis

  2004cites this paper
• The effects of 99mTc-HMPAO-labelled leucocyte scan on human karyotype

  2003influential citation
• Labeling of mixed leukocytes with (99m)Tc-HMPAO causes severe chromosomal aberrations in lymphocytes.

  2002cites this paper
• Evaluation of the cytotoxic and mutagenic potentiality of technetium-99m in Escherichi coli.

  2002cites this paper
• Dosimetry from organ to cellular dimensions.

  2001cites this paper
• Studies on white blood cell labelling: 99Tcm-HMPAO preferentially labels granulocytes

  2001cites this paper
• Estimation of risk based on biological dosimetry for patients treated with radioiodine.

  1999cites this paper
• Evaluation of technetium-99m decay on Escherichia coli inactivation: effects of physical or chemical agents.

  1998cites this paper
• Radiotoxicity after iodine-131 therapy for thyroid cancer using the micronucleus assay.

  1998cites this paper
• Microdosimetry in Labelled Leucocytes

  1998cites this paper
• Biological consequences of the heterogeneous irradiation of lymphocytes during technetium-99m hexamethylpropylene amine oxime white blood cell labelling

  1998cites this paper
• Relationship of decreased chemotaxis of technetium-99m-HMPAO-labeled lymphocytes to apoptosis.

  1997cites this paper
• Radiopharmaceuticals for the study of inflammatory processes: a review.

  1997cites this paper
• Radiation Induced Chromosomal Damage to Lymphocytes in Usual 99mTc-HMPAO Leukocyte Preparations

  1994cites this paper
• Radiation risks from imaging of intestinal and abdominal inflammation.

  1994cites this paper
• A Simple Technique for Obtaining ^ Tc-Labeled Leukocytes and Their Organ Distribution in Rabbits

  1993cites this paper